Yves Sagot
Director/Board Member at BIOSENIC SA
Profile
Yves Sagot was the founder of RELIEF THERAPEUTICS Holding SA, where he held the title of Chief Scientific Officer from 2016 to 2020.
He is also the founder of Sonnet BioTherapeutics CH SA. Currently, Dr. Sagot is an Independent Director at BioSenic SA since 2023.
Dr. Sagot has a graduate and doctorate degree from the University of Geneva and a doctorate degree from Université Toulouse III - Paul Sabatier.
Yves Sagot active positions
Companies | Position | Start |
---|---|---|
BIOSENIC SA | Director/Board Member | 26/01/2023 |
Former positions of Yves Sagot
Companies | Position | End |
---|---|---|
RELIEF THERAPEUTICS HOLDING SA | Founder | 07/10/2020 |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Founder | - |
Training of Yves Sagot
University of Geneva | Doctorate Degree |
Université Toulouse III - Paul Sabatier | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
RELIEF THERAPEUTICS HOLDING SA | Health Technology |
BIOSENIC SA | Health Technology |
Private companies | 1 |
---|---|
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Yves Sagot